{"id":"https://openalex.org/W2004034072","doi":"https://doi.org/10.1055/s-2004-828676","title":"Clinical Trial Results and Treatment Resistance with Lamivudine in Hepatitis B","display_name":"Clinical Trial Results and Treatment Resistance with Lamivudine in Hepatitis B","publication_year":2004,"publication_date":"2004-02-01","ids":{"openalex":"https://openalex.org/W2004034072","doi":"https://doi.org/10.1055/s-2004-828676","mag":"2004034072","pmid":"https://pubmed.ncbi.nlm.nih.gov/15192799"},"language":"en","primary_location":{"id":"doi:10.1055/s-2004-828676","doi":"https://doi.org/10.1055/s-2004-828676","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2004-828676","pdf_url":null,"source":{"id":"https://openalex.org/S176130430","display_name":"Seminars in Liver Disease","issn_l":"0272-8087","issn":["0272-8087","1098-8971"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in Liver Disease","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009050197","display_name":"Teresa Lyn Wright","orcid":"https://orcid.org/0000-0002-9174-9409","observed_orcids":["https://orcid.org/0000-0002-9174-9409"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Teresa L Wright","raw_affiliation_strings":["Department of Veterans Affairs Medical Center, University of California, San Francisco, 94121, USA. twright@itsa.ucsf.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Veterans Affairs Medical Center, University of California, San Francisco, 94121, USA. twright@itsa.ucsf.edu","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5009050197"],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":null,"apc_paid":null,"fwci":3.1157,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.91038204,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"24","issue":null,"first_page":"31","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10340","display_name":"Hepatitis B Virus Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":1.0},{"id":"https://openalex.org/keywords/chronic-hepatitis-b","display_name":"chronic hepatitis B","score":0.9670000076293945},{"id":"https://openalex.org/keywords/antiviral-resistance","display_name":"antiviral resistance","score":0.7459999918937683},{"id":"https://openalex.org/keywords/hbeag-seroconversion","display_name":"HBeAg seroconversion","score":0.9800000190734863},{"id":"https://openalex.org/keywords/hbeag-loss","display_name":"HBeAg loss","score":0.9649999737739563},{"id":"https://openalex.org/keywords/alanine-aminotransferase-normalization","display_name":"alanine aminotransferase normalization","score":0.949999988079071},{"id":"https://openalex.org/keywords/histological-improvement","display_name":"histological improvement","score":0.6930000185966492},{"id":"https://openalex.org/keywords/viral-suppression","display_name":"viral suppression","score":0.6150000095367432},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.5410000085830688},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.8650000095367432}],"concepts":[{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.9209150671958923},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8032447695732117},{"id":"https://openalex.org/C2777451964","wikidata":"https://www.wikidata.org/wiki/Q2141450","display_name":"Seroconversion","level":3,"score":0.7966256141662598},{"id":"https://openalex.org/C2775940106","wikidata":"https://www.wikidata.org/wiki/Q10478733","display_name":"HBeAg","level":5,"score":0.6594837307929993},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5820317268371582},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5602307915687561},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.4771575331687927},{"id":"https://openalex.org/C2777382497","wikidata":"https://www.wikidata.org/wiki/Q6853","display_name":"Hepatitis B","level":2,"score":0.4576399326324463},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.44146230816841125},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3888811469078064},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.3667171001434326},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.31581056118011475},{"id":"https://openalex.org/C2777410769","wikidata":"https://www.wikidata.org/wiki/Q2282887","display_name":"HBsAg","level":4,"score":0.19508296251296997}],"mesh":[{"descriptor_ui":"D000410","descriptor_name":"Alanine Transaminase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004279","descriptor_name":"DNA, Viral","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006513","descriptor_name":"Hepatitis B e Antigens","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D019694","descriptor_name":"Hepatitis B, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-2004-828676","doi":"https://doi.org/10.1055/s-2004-828676","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2004-828676","pdf_url":null,"source":{"id":"https://openalex.org/S176130430","display_name":"Seminars in Liver Disease","issn_l":"0272-8087","issn":["0272-8087","1098-8971"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in Liver Disease","raw_type":"journal-article"},{"id":"pmid:15192799","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15192799","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in liver disease","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1984075841","https://openalex.org/W2136425954","https://openalex.org/W2137544368","https://openalex.org/W2370577029","https://openalex.org/W2084713036","https://openalex.org/W2462805350","https://openalex.org/W2363308122","https://openalex.org/W2363424319","https://openalex.org/W2363169485","https://openalex.org/W1847424568"],"abstract_inverted_index":{"Lamivudine":[0],"is":[1,120,148],"an":[2],"effective":[3],"first-line":[4],"therapy":[5],"for":[6,40,155],"chronic":[7],"hepatitis":[8,41],"B":[9,42],"virus":[10],"(HBV)":[11],"infection,":[12],"accomplishing":[13],"the":[14,30,65,71,85,115,153],"goals":[15],"of":[16,20,37,51,68,73,78,87,101,117,125],"viral":[17],"suppression,":[18],"normalization":[19],"alanine":[21],"aminotransferase":[22],"(ALT)":[23],"levels,":[24],"histological":[25,136],"improvement,":[26],"and":[27,53,80,135,138],"seroconversion.":[28,58],"In":[29,89],"lamivudine":[31],"clinical":[32],"trials,":[33],"up":[34],"to":[35,98,114,141,151],"32%":[36],"patients":[38,126],"positive":[39],"e":[43],"antigen":[44],"(HBeAg)":[45],"lost":[46],"HBeAg":[47,57,74],"after":[48,96],"1":[49],"year":[50],"treatment,":[52,111],"approximately":[54],"18%":[55],"achieved":[56],"ALT":[59],"levels":[60],"greater":[61],"than":[62],"five":[63],"times":[64],"upper":[66],"limit":[67],"normal":[69],"increased":[70],"likelihood":[72],"loss.":[75],"The":[76],"rates":[77],"seroconversion":[79],"resistance":[81],"both":[82],"increase":[83],"with":[84],"length":[86],"treatment.":[88],"HBeAg-negative":[90],"patients,":[91],"two":[92],"thirds":[93],"showed":[94],"response":[95,105,158],"6":[97],"12":[99],"months":[100],"therapy,":[102],"but":[103],"this":[104],"diminished":[106],"over":[107],"time":[108],"despite":[109],"continued":[110],"largely":[112],"due":[113],"emergence":[116],"resistance.":[118],"Resistance":[119,130],"present":[121],"in":[122],"nearly":[123],"70%":[124],"at":[127],"5":[128],"years.":[129],"reverses":[131],"prior":[132],"biochemical,":[133],"virological,":[134],"gains":[137],"can":[139],"lead":[140],"progressive":[142],"liver":[143],"failure.":[144],"Careful":[145],"patient":[146],"selection":[147],"important,":[149],"therefore,":[150],"maximize":[152],"potential":[154],"a":[156],"treatment":[157],"under":[159],"limited":[160],"therapy.":[161]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}